Legal & General Group’s Solid Biosciences SLDB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.3K | Buy |
6,011
+4,063
| +209% | +$19.8K | ﹤0.01% | 2863 |
|
|
2025
Q1 | $7.21K | Hold |
1,948
| – | – | ﹤0.01% | 3229 |
|
|
2024
Q4 | $7.79K | Hold |
1,948
| – | – | ﹤0.01% | 3295 |
|
|
2024
Q3 | $13.6K | Hold |
1,948
| – | – | ﹤0.01% | 3196 |
|
|
2024
Q2 | $11K | Buy |
+1,948
| New | +$11K | ﹤0.01% | 3279 |
|
|
2022
Q2 | – | Sell |
-317
| Closed | -$6K | – | 3641 |
|
|
2022
Q1 | $6K | Hold |
317
| – | – | ﹤0.01% | 3492 |
|
|
2021
Q4 | $8K | Hold |
317
| – | – | ﹤0.01% | 3500 |
|
|
2021
Q3 | $11K | Hold |
317
| – | – | ﹤0.01% | 3434 |
|
|
2021
Q2 | $17K | Buy |
317
+145
| +84% | +$7.78K | ﹤0.01% | 3351 |
|
|
2021
Q1 | $14K | Buy |
172
+28
| +19% | +$2.28K | ﹤0.01% | 3285 |
|
|
2020
Q4 | $16K | Hold |
144
| – | – | ﹤0.01% | 3178 |
|
|
2020
Q3 | $4K | Sell |
144
-81
| -36% | -$2.25K | ﹤0.01% | 3394 |
|
|
2020
Q2 | $10K | Buy |
225
+43
| +24% | +$1.91K | ﹤0.01% | 3312 |
|
|
2020
Q1 | $7K | Sell |
182
-71
| -28% | -$2.73K | ﹤0.01% | 3224 |
|
|
2019
Q4 | $17K | Buy |
253
+8
| +3% | +$538 | ﹤0.01% | 3223 |
|
|
2019
Q3 | $38K | Buy |
245
+83
| +51% | +$12.9K | ﹤0.01% | 2856 |
|
|
2019
Q2 | $12K | Hold |
162
| – | – | ﹤0.01% | 3328 |
|
|
2019
Q1 | $23K | Buy |
162
+14
| +9% | +$1.99K | ﹤0.01% | 3049 |
|
|
2018
Q4 | $60K | Buy |
148
+26
| +21% | +$10.5K | ﹤0.01% | 2630 |
|
|
2018
Q3 | $86K | Buy |
122
+40
| +49% | +$28.2K | ﹤0.01% | 2555 |
|
|
2018
Q2 | $44K | Sell |
82
-25
| -23% | -$13.4K | ﹤0.01% | 2805 |
|
|
2018
Q1 | $12K | Buy |
+107
| New | +$12K | ﹤0.01% | 3198 |
|